Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy: Phase II—Results of EORTC Study 30986

PURPOSE: There is no standard treatment for patients with advanced urothelial cancer who are ineligible (“unfit”) for cisplatin-based chemotherapy (CHT). To compare the activity and safety of two CHT combinations in this patient group, a randomized phase II/III trial was conducted by the EORTC (Euro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: De Santis, Maria, Bellmunt, Joaquim, Mead, Graham, Kerst, J. Martijn, Leahy, Michael, Maroto, Pablo, Skoneczna, Iwona, Marreaud, Sandrine, de Wit, Ronald, Sylvester, Richard
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2792956/
https://ncbi.nlm.nih.gov/pubmed/19786668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.21.4924
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares